+ +

•  

   

     Western blot analysis of Renin expression in K562 cell lysate.    

  
  

Renin antibodies are immunological tools used to detect and study renin, a protease enzyme central to the renin-angiotensin system (RAS), which regulates blood pressure and fluid balance. Renin is primarily synthesized by juxtaglomerular cells in the kidneys and catalyzes the conversion of angiotensinogen to angiotensin I, initiating a cascade that ultimately influences vasoconstriction, aldosterone secretion, and sodium retention. Dysregulation of renin is linked to hypertension, kidney diseases, and cardiovascular disorders.

Renin antibodies, including monoclonal and polyclonal variants, enable researchers to quantify renin levels, localize its expression in tissues, and investigate its role in pathological conditions. They are critical in experimental models studying RAS hyperactivity, such as renal artery stenosis or heart failure. Additionally, these antibodies aid in diagnosing renin-secreting tumors (e.g., juxtaglomerular cell tumors) and differentiating causes of hypertension in clinical settings.

Recent advancements in antibody engineering have improved specificity and reduced cross-reactivity with related proteases, enhancing their reliability in immunoassays (e.g., ELISA, Western blot) and immunohistochemistry. However, challenges remain, including variability in renin isoforms across species and tissues. Ongoing research focuses on developing therapeutic antibodies targeting renin or its pathway components to modulate RAS activity, offering potential treatments for hypertension and organ damage.